FKBP4 containing tetratricopeptide repeat domains has been reported to regulate the stability of estrogen receptors in breast cancer9 and integrate FKBP4/Hsp90/IKK with the FKBP4/Hsp70/RelA complex to promote lung cancer progression.10 This evidence concerns the gene FKBP4 and lung carcinoma.